4.4 Article

Selecting the Right Tool For the Job

Journal

AMERICAN JOURNAL OF BIOETHICS
Volume 15, Issue 4, Pages 4-10

Publisher

ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/15265161.2015.1010993

Keywords

Ebola treatment trials; compassionate access; adaptive trial design; international research; expanded access; research ethics; placebo controls; selection trials; randomized controlled trials (RCT); cluster randomized designs; sequential designs; standard of care controls; elimination of inferior treatments

Funding

  1. NIMH NIH HHS [P30 MH043520] Funding Source: Medline
  2. NINDS NIH HHS [R13 NS065622] Funding Source: Medline

Ask authors/readers for more resources

There are competing ethical concerns when it comes to designing any clinical research study. Clinical trials of possible treatments for Ebola virus are no exception. If anything, the competing ethical concerns are exacerbated in trying to find answers to a deadly, rapidly spreading, infectious disease. The primary goal of current research is to identify experimental therapies that can cure Ebola or cure it with reasonable probability in infected individuals. Pursuit of that goal must be methodologically sound, practical and consistent with prevailing norms governing human subjects research. Some maintain that only randomized controlled trials (RCTs) with a placebo or standard-of-care arm can meet these conditions. We maintain that there are alternative trial designs that can do so as well and that sometimes these are preferable to RCTs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available